现代肿瘤医学
現代腫瘤醫學
현대종류의학
Journal of Modern Oncology
2015年
23期
3397-3400
,共4页
汤建才%龙凤%李丹%王永生
湯建纔%龍鳳%李丹%王永生
탕건재%룡봉%리단%왕영생
重组人白细胞介素 - 7%原核表达%生物活性
重組人白細胞介素 - 7%原覈錶達%生物活性
중조인백세포개소 - 7%원핵표체%생물활성
recombinant human interleukin - 7%prokaryotic expression%biologic activity
目的:构建重组质粒 pET32a - hIL -7,诱导表达,纯化并鉴定目的蛋白。方法:将人白介素-7基因克隆到原核表达载体 pET32a(+)上,得到重组质粒 pET32a - hIL -7,转化大肠杆菌 BL21(DE3),经 IPTG 诱导得到融合蛋白 Trx - hIL -7。融合蛋白主要以包涵体形式存在。包涵体通过复性、酶切、纯化等步骤处理。利用 Western blot 鉴定重组蛋白,对其生物学活性用其依赖性细胞株2E8增殖实验测定。结果:成功构建重组质粒 pET32a - hIL -7。包涵体通过透析复性,肠激酶切,镍柱纯化等步骤得到重组蛋白人 IL -7。纯化的重组蛋白经 Western blot 鉴定能与抗人的 IL -7抗体特异性结合。经体外细胞实验检测证明,纯化的重组蛋白具有生物学活性。结论:得到了有活性的重组蛋白 IL -7,为研究其功能奠定了基础。
目的:構建重組質粒 pET32a - hIL -7,誘導錶達,純化併鑒定目的蛋白。方法:將人白介素-7基因剋隆到原覈錶達載體 pET32a(+)上,得到重組質粒 pET32a - hIL -7,轉化大腸桿菌 BL21(DE3),經 IPTG 誘導得到融閤蛋白 Trx - hIL -7。融閤蛋白主要以包涵體形式存在。包涵體通過複性、酶切、純化等步驟處理。利用 Western blot 鑒定重組蛋白,對其生物學活性用其依賴性細胞株2E8增殖實驗測定。結果:成功構建重組質粒 pET32a - hIL -7。包涵體通過透析複性,腸激酶切,鎳柱純化等步驟得到重組蛋白人 IL -7。純化的重組蛋白經 Western blot 鑒定能與抗人的 IL -7抗體特異性結閤。經體外細胞實驗檢測證明,純化的重組蛋白具有生物學活性。結論:得到瞭有活性的重組蛋白 IL -7,為研究其功能奠定瞭基礎。
목적:구건중조질립 pET32a - hIL -7,유도표체,순화병감정목적단백。방법:장인백개소-7기인극륭도원핵표체재체 pET32a(+)상,득도중조질립 pET32a - hIL -7,전화대장간균 BL21(DE3),경 IPTG 유도득도융합단백 Trx - hIL -7。융합단백주요이포함체형식존재。포함체통과복성、매절、순화등보취처리。이용 Western blot 감정중조단백,대기생물학활성용기의뢰성세포주2E8증식실험측정。결과:성공구건중조질립 pET32a - hIL -7。포함체통과투석복성,장격매절,얼주순화등보취득도중조단백인 IL -7。순화적중조단백경 Western blot 감정능여항인적 IL -7항체특이성결합。경체외세포실험검측증명,순화적중조단백구유생물학활성。결론:득도료유활성적중조단백 IL -7,위연구기공능전정료기출。
Objective:To acquire recombinant human interleukin 7 prokaryotic expressing plasmid,fusion protein is expressed,purified and identified. Methods:The hIL - 7 gene was inserted into the prokaryotic expressing vector pET - 32a( + )to acquire pET32 - hIL - 7 and transformed into BL21(DE3)cells. IPTG induced the expression of fusion protein Trx - IL - 7. The induced product was washed,dissolved and purified by affinity chromatogarphy under renaturing condition. IL - 7 was identified by Western blot,and the biologic activity was detected by proliferation of IL - 7 dependence cell 2E8. Results:The recombinant plasmid pET32 / rhlL - 7 has been constructed correctly. The recombinant hlL - 7 was gained after gradient dialysis,enzyme digestion and purified,which has the right immunology specificity and biologic activity. Conclusion:The recombinant human interleukin - 7 with biologic activity has been acquired,which lay the foundation for the further study of function of IL - 7.